Authors
Xia Ling, Zhiyao Li, Chongzhi Wu, Yufu Tang, Zesen Lin, Siqin Chen, Wentao Song, Bowen Li, Bin Liu
Published in
Advanced materials (Deerfield Beach, Fla.). Pages e74143. Jul 17, 2026. Epub Jul 17, 2026.
Abstract
Type І photosensitizers (PSs) offer a promising strategy to overcome tumor hypoxia in photodynamic therapy (PDT) owing to their minimal oxygen dependence. However, their rational design remains elusive due to insufficient understanding of structure-property relationships. Herein, we leverage donor-π bridge-acceptor (D-π-A) conjugate modulation to design phthalonitrile-based Type І PSs through the systematic regulation of four critical parameters, including ΔEST, T1 energy level, redox potential and steric hindrance, thereby optimizing efficient electron transfer pathway. These PSs exhibit aggregate-induced Type І reactive oxygen species (ROS) generation, driven by favorable intermolecular electronic interactions. Among them, DTPCH3 demonstrates the highest Type І ROS production, attributed to its minimal ΔES1-T2 and the most effective intermolecular electron transfer interactions. Upon encapsulation with amphiphilic polymer F127, DTPCH3 nanoparticles (DTPCH3_NPs) retain efficient O2 •- and HO• generation, resulting in potent cancer cell ablation and good hypoxic tolerance. In vivo studies further confirm significant tumor suppression by DTPCH3_NPs. Overall, this work establishes a molecular design strategy for Type I PSs, opening new avenues for the development of next-generation PDT agents.
PMID:
42464781
Bibliographic data and abstract were imported from PubMed on 17 Jul 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1
- Comments 0